Sangamo Therapeutics, Inc. (SGMO)

Sangamo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	29.62	41.92	45.2	100.44	178.87	131.33
Short-Term Investments	-	-	35.8	177.19	197.68	510.09
Cash & Short-Term Investments	29.62	41.92	81	277.63	376.55	641.42
Cash Growth	-24.45%	-48.25%	-70.82%	-26.27%	-41.30%	76.96%
Total Trade Receivables	5.13	4.6	4.07	4.47	6.36	6.26
Other Current Assets	9.34	5.18	9.26	18.22	15.86	11.99
Total Current Assets	44.08	51.69	94.33	300.33	398.77	659.67
Net Property, Plant & Equipment	29.22	34.76	52.87	125.53	124.7	112.37
Other Intangible Assets	-	-	-	50.73	53.76	58.13
Goodwill	-	-	-	37.55	39.7	42.8
Long-Term Investments	-	-	-	29.85	88.17	50.53
Other Long-Term Assets	15.35	15.19	18.13	18.52	16.82	15.06
Total Assets	88.64	101.64	165.32	562.51	721.92	938.55
Accounts Payable	15.56	15.49	15.26	22.42	9.76	12.55
Accrued Expenses	27.01	22.76	32.47	37.51	32.42	39.35
Unearned Revenue	7.56	7.56	-	51.78	85.71	91.64
Total Current Liabilities	50.13	45.81	47.73	111.71	127.89	143.55
Long-Term Leases	25.42	26.25	33.52	38.99	44.06	38.4
Other Long-Term Liabilities	6.85	6.81	1.19	116.85	174.64	259.24
Total Long-Term Liabilities	32.28	33.06	34.7	155.84	218.69	297.64
Total Liabilities	82.4	78.87	82.43	267.55	346.58	441.18
Common Stock	3.22	2.13	1.78	1.67	1.46	1.42
Additional Paid-in Capital	1,594	1,532	1,492	1,450	1,334	1,269
Accumulated Other Comprehensive Income	-1.45	-7.53	-4.6	-8.4	-3.99	5.42
Retained Earnings	-1,590	-1,504	-1,406	-1,149	-956.27	-777.98
Total Common Shareholders' Equity	6.24	22.77	82.89	294.96	375.34	498.23
Minority Interest	-	-	-	-	-	-0.87
Shareholders' Equity	6.24	22.77	82.89	294.96	375.34	497.37
Total Liabilities & Equity	88.64	101.64	165.32	562.51	721.92	938.55
Total Debt	25.42	26.25	33.52	38.99	44.06	38.4
Net Cash (Debt)	4.19	15.67	47.49	238.65	332.49	603.03
Net Cash Growth	-73.24%	-67.01%	-80.10%	-28.23%	-44.86%	87.69%
Net Cash Per Share	0.02	0.08	0.27	1.55	2.30	4.49
Book Value	6.24	22.77	82.89	294.96	375.34	498.23
Book Value Per Share	0.03	0.11	0.48	1.91	2.60	3.71
Tangible Book Value	6.24	22.77	82.89	206.68	281.88	397.31
Tangible Book Value Per Share	0.03	0.11	0.48	1.34	1.95	2.96

Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q